<DOC>
	<DOC>NCT00500370</DOC>
	<brief_summary>This is a multicenter study designed to compare the effect of exenatide plus a lifestyle modification plan versus placebo plus a lifestyle modification plan on weight loss in non-diabetic, obese subjects.</brief_summary>
	<brief_title>A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients</brief_title>
	<detailed_description />
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<criteria>Have a Body Mass Index (BMI) &gt;= 30kg/m^2 Have ever participated in this study previously, or any other study using exenatide (AC2993/LY2148568) or GLP1 analogs Have participated in an interventional medical, surgical, or pharmaceutical study (a study in which an experimental, drug, medical, or surgical treatment was given) within 30 days of study start (this criterion includes drugs that have not received regulatory approval for any indication at the time of study entry) Diagnosis of diabetes mellitus (other than gestational diabetes), or previous use of antidiabetic medications for &gt; 3 months Have had a change in prescribed lipidlowering or blood pressure agents within 4 weeks of screening Used drugs for weight loss (e.g., Xenical [orlistat], Meridia [sibutramine], Acutrim [phenylpropanolamine], Accomplia [rimonabant], Alli [lowdose orlistat], or other similar overthecounter weight loss remedies or medications) within 3 months of screening Are actively participating in, or have participated in a formal weight loss program within the last 3 months Have a history of chronic use of drugs that directly affect gastrointestinal motility, including, but not limited to Reglan (metoclopramide) and chronic macrolide antibiotics Have been treated with any antidiabetic medications within 3 months of screening Are receiving chronic (lasting longer than 2 weeks) systemic glucocorticoid therapy or have received such therapy within the 4 weeks immediately prior to study start Have had bariatric surgery Have had an organ transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>exenatide</keyword>
	<keyword>obesity</keyword>
	<keyword>diabetes</keyword>
	<keyword>Amylin</keyword>
	<keyword>Lilly</keyword>
</DOC>